Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase

Neonatology

Volumn 102, Issue 2, 2012, Pages 139-144

  Parad, Richard B ^a,b,c   Allred, Elizabeth N ^c,d   Rosenfeld, Warren N ^f   Davis, Jonathan M ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Children's Hospital   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Antioxidants; Extremely low gestational age newborns; Prematurity; Reactive oxygen species; Retinopathy of prematurity; Superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; PLACEBO; RECOMBINANT COPPER ZINC SUPEROXIDE DISMUTASE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; EXTREMELY LOW BIRTH WEIGHT; EYE EXAMINATION; GESTATIONAL AGE; HUMAN; INCIDENCE; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; NEWBORN; POST HOC ANALYSIS; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; RISK FACTOR; RISK REDUCTION; TREATMENT OUTCOME;

ANTIOXIDANTS; BRONCHOPULMONARY DYSPLASIA; DOUBLE-BLIND METHOD; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; LOGISTIC MODELS; OXYGEN INHALATION THERAPY; RECOMBINANT PROTEINS; RETINOPATHY OF PREMATURITY; SEVERITY OF ILLNESS INDEX; SUPEROXIDE DISMUTASE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84862255414     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000336639     Document Type: Article

References (25)

1. Tin W, Milligan DW, Pennefather P, Hey E: Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed 2001; 84:F106-F110.
2. Darlow BA, Hutchinson JL, Henderson- Smart DJ, Donoghue DA, Simpson JM, Evans NJ: Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Australian and New Zealand Neonatal Network. Pediatrics 2005; 115: 990-996.
3. Raghuveer TS, Bloom BT: A paradigm shift in the prevention of retinopathy of prematurity. Neonatology 2011; 100: 116-129.
4. Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, Tung B; Early Treatment for Retinopathy of Prematurity Cooperative Group: The incidence and course of retinopathy of prematurity: findings from the Early Treatment for Retinopathy of Prematurity study. Pediatrics 2005; 116: 15-23.
5. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, Bauer CR, Donovan EF, Korones SB, Laptook AR, Lemons JA, Oh W, Papile LA, Shankaran S, Stevenson DK, Tyson JE, Poole WK; NICHD Neonatal Research Network: Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007; 196: 147.e1-147.e8.
6. Austeng D, Kallen KB, Ewald UW, Jakobsson PG, Holmstrom GE: Incidence of retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden. Arch Ophthalmol 2009; 127: 1315-1319.
7. Lad EM, Hernandez-Boussard T, Morton JM, Moshfeghi DM: Incidence of retinopathy of prematurity in the United States: 1997 through 2005. Am J Ophthalmol 2009; 148: 451-458.
8. Saugstad OD, Aune D: In search of the optimal oxygen xaturation for extremely low birth weight infants: A systematic review and meta-analysis. Neonatology 2011; 100: 1-8.
9. Rivera JC, Sapieha P, Joyal JS, Duhamel F, Shao Z, Sitaras N, Picard E, Zhou E, Lachapelle P, Chemtob S: Understanding retinopathy of prematurity: update on pathogenesis. Neonatology 2011; 100: 343-353.
10. Frank L, Sosenko IR: Failure of premature rabbits to increase antioxidant enzymes during hyperoxic exposure: increased susceptibility to pulmonary oxygen toxicity compared with term rabbits. Pediatr Res 1991; 29: 292-296.
11. Ushio-Fukai M: Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc Res 2006; 71: 226-235.
12. Saugstad OD, Speer CP, Halliday HL: Oxygen saturation in immature babies: revisited with updated recommendations. Neonatology 2011; 100: 217-218.
13. Rosenfeld W, Davis J: Prevention of oxygen radical disease in the newborn: possible therapeutic approaches. Semin Neonatol 1998; 3: 239-244.
14. Davis J, Parad R, Michele T, Allred E, Price A, Rosenfeld W; North American Recombinant Human CuZnSOD Study Group: Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 2003; 111: 469-476.
15. Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2006; 117: 572-576.
16. Sahgal N, Davis JM, Robbins C, Horowitz S, Langenback EG, Perry RH, Colflesh D, Tierney J, Simon SR: Localization and activity of recombinant human Cu/Zn superoxide dismutase following intratracheal administration. Am J Physiol Lung Cell Mol Physiol 1996; 71:L230-L235.
17. Rosenfeld WN, Davis JM, Parton L, Richter SE, Price A, Flaster E, Kassem N: Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1996; 97: 811-817.
18. Pierce EA, Foley ED, Smith LE: Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 1996; 114: 1219-1228.
19. Chen J, Smith LE: Retinopathy of prematurity. Angiogenesis 2007; 10: 133-140.
20. Gu X, El Remessy AB, Brooks SE, Al Shabrawey M, Tsai NT, Caldwell RB: Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. Am J Physiol Cell Physiol 2003; 285:C546-C554.
21. Hughes S, Yang H, Chan-Ling T: Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci 2000; 41: 1217-1228.
22. Chow LC, Wright KW, Sola A: Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 2003; 111: 339-345.
23. Raju TN, Langenberg P, Bhutani V, Quinn GE: Vitamin E prophylaxis to reduce retinopathy of prematurity: A reappraisal of published trials. J Pediatr 1997; 131: 844-850.
24. Johnson L, Quinn GE, Abbasi S, Otis C, Goldstein D, Sacks L, Porat R, Fong E, Delivoria- Papadopoulos M, Peckham G, et al: Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: A controlled clinical trial. J Pediatr 1989; 114: 827-838.
25. Phelps DL, Lakatos L, Watts JL: D-Penicillamine for preventing retinopathy of prematurity in preterm infants. Cochrane Database Syst Rev 2001;(1):CD001073.